Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior.

Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV.

Am J Surg Pathol. 2001 Dec;25(12):1478-84.

PMID:
11717536
2.

Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.

Mechler C, Bounacer A, Suarez H, Saint Frison M, Magois C, Aillet G, Gaulier A.

Br J Cancer. 2001 Dec 14;85(12):1831-7.

3.

RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).

Nakazawa T, Kondo T, Kobayashi Y, Takamura N, Murata S, Kameyama K, Muramatsu A, Ito K, Kobayashi M, Katoh R.

Cancer. 2005 Sep 1;104(5):943-51.

4.

Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics.

Cheung CC, Boerner SL, MacMillan CM, Ramyar L, Asa SL.

Am J Surg Pathol. 2000 Dec;24(12):1622-6.

PMID:
11117782
5.

Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma.

Rhoden KJ, Johnson C, Brandao G, Howe JG, Smith BR, Tallini G.

Lab Invest. 2004 Dec;84(12):1557-70.

6.

Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases.

Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV.

Am J Surg Pathol. 2010 Jan;34(1):44-52. doi: 10.1097/PAS.0b013e3181c46677.

PMID:
19956062
7.

New breakpoints in both the H4 and RET genes create a variant of PTC-1 in a post-Chernobyl papillary thyroid carcinoma.

Elisei R, Romei C, Soldatenko PP, Cosci B, Vorontsova T, Vivaldi A, Basolo F, Cherstvoy ED, Pinchera A, Pacini F.

Clin Endocrinol (Oxf). 2000 Jul;53(1):131-6.

PMID:
10931090
8.

Oncogene profile of papillary thyroid carcinoma.

Sugg SL, Ezzat S, Zheng L, Freeman JL, Rosen IB, Asa SL.

Surgery. 1999 Jan;125(1):46-52.

PMID:
9889797
9.

Papillary carcinoma of the breast lacks evidence of RET rearrangements despite morphological similarities to papillary thyroid carcinoma.

Hameed O, Perry A, Banerjee R, Zhu X, Pfeifer JD.

Mod Pathol. 2009 Sep;22(9):1236-42. doi: 10.1038/modpathol.2009.91. Epub 2009 Jun 19.

10.
11.

RET/PTC rearrangements arising from a small population of papillary thyroid carcinoma cells, possible candidate for passenger mutation.

Nakazawa T, Murata S, Kondo T, Niu D, Mochizuki K, Kawasaki T, Yamane T, Nakamura N, Katoh R.

Virchows Arch. 2009 Jul;455(1):35-41. doi: 10.1007/s00428-009-0789-8. Epub 2009 Jun 3.

PMID:
19495791
12.

Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.

Wenig BM, Thompson LD, Adair CF, Shmookler B, Heffess CS.

Cancer. 1998 Feb 15;82(4):740-53.

PMID:
9477108
13.

Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.

Zidan J, Karen D, Stein M, Rosenblatt E, Basher W, Kuten A.

Cancer. 2003 Mar 1;97(5):1181-5.

14.

Detection of RET/PTC oncogene rearrangements in Korean papillary thyroid carcinomas.

Chung JH, Hahm JR, Min YK, Lee MS, Lee MK, Kim KW, Nam SJ, Yang JH, Ree HJ.

Thyroid. 1999 Dec;9(12):1237-43.

PMID:
10646664
15.

Ret/PTC3 is the most frequent form of gene rearrangement in papillary thyroid carcinomas in Japan.

Kitamura Y, Minobe K, Nakata T, Shimizu K, Tanaka S, Fujimori M, Yokoyama S, Ito K, Onda M, Emi M.

J Hum Genet. 1999;44(2):96-102.

PMID:
10083732
17.

Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma.

Caria P, Dettori T, Frau DV, Di Oto E, Morandi L, Parmeggiani A, Tallini G, Vanni R.

Am J Surg Pathol. 2012 Sep;36(9):1415-20. doi: 10.1097/PAS.0b013e318264bdd6.

PMID:
22895275
18.

RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas.

Nibu K, Otsuki N, Nakao K, Sugasawa M, Rothstein JL.

Eur Arch Otorhinolaryngol. 2005 May;262(5):368-73. Epub 2004 Sep 11.

PMID:
15368067
19.

Temporal trends and clinical correlates for the ret/PTC1 mutation in papillary thyroid carcinoma.

Burgess JR, Skabo S, McArdle K, Tucker P.

ANZ J Surg. 2003 Jan-Feb;73(1-2):31-5.

PMID:
12534735
20.

Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression.

Asioli S, Erickson LA, Righi A, Jin L, Volante M, Jenkins S, Papotti M, Bussolati G, Lloyd RV.

Mod Pathol. 2010 Sep;23(9):1269-78. doi: 10.1038/modpathol.2010.117. Epub 2010 Jun 18.

Supplemental Content

Support Center